Essity — Investor Presentation 2026

May 7, 2026

essity

Press release

Stockholm, May 7, 2026

Today Essity hosts its Capital Markets Day

• Accelerating progress by sharpening focus and execution

Today, the hygiene and health company Essity hosts its Capital Markets Day at the company's office in Gothenburg, Sweden. The day will also be live-streamed via the link Essity CMD 2026 Webcast with the opportunity to ask questions.

Between 09:00 -13:00 CET, Essity's strategy for profitable growth and initiatives to increase value creation and faster achieve the company's financial targets will be presented.

Agenda for the day:

• Essity Group - Ulrika Kolsrud, President & CEO
• Health & Medical - Anand Chandarana, President Health & Medical
• Personal Care - Tuomas Yrjölä, President Personal Care
• Consumer Tissue - Volker Zöller, President Consumer Tissue
• Professional Hygiene - Pablo Fuentes, President Professional Hygiene
• Essity Group financials - Fredrik Rystedt, CFO & EVP
• Summary & Q&A

"I look forward to sharing how we are building an even stronger Essity going forward. By sharpening our innovation agenda, lowering our costs to increase growth investments, and accelerating the portfolio shift, we will increase our value creation," says Ulrika Kolsrud, President and CEO, Essity.

The financial targets of an annual organic sales growth >3% and an EBITA margin excl. IAC >15% remains unchanged. During the day, it will be presented how the company's business areas will contribute to the Group targets:

• Annual organic sales growth for Health & Medical 3-4%, for Personal Care 5-6%, for Consumer Tissue 1-2% and for Professional Hygiene 2-3%
• EBITA margin excl. IAC for Health & Medical >19%, for Personal Care >16%, for Consumer Tissue >12% and for Professional Hygiene >18%

About Essity

Essity is a global, leading hygiene and health company. Every day, our products, solutions and services are used by a billion people around the world. Our purpose is to break barriers to well-being for the benefit of consumers, patients, caregivers, customers and society. Sales are conducted in approximately 150 countries under the leading global brands TENA and Tork, and other strong brands such as Actimove, Cutimed, JOBST, Knix, Leukoplast, Libero, Libresse, Lotus, Modibodi, Nosotras, Saba, Tempo, TOM Organic and Zewa. In 2025, Essity had net sales of approximately SEK 138bn (EUR 13bn) and employed 36,000 people. The company's headquarters is located in Stockholm, Sweden and Essity is listed on Nasdaq Stockholm. More information at essity.com.

TONA

TENA

Leukoplast

Libero

Actimove

Cutimed

KNOX

KOL

Libero

TOM

knix

Modibodi

---

The day also includes a guided tour of the R&D operations in Gothenburg, demonstrations of innovations and product offerings, and the opportunity to visit one of Essity's production facilities in Lilla Edet or Falkenberg.

The presentations will be live-streamed via the link: Essity CMD 2026 Webcast with the opportunity to ask questions, and will also be available after the event at essity.com.

NB: This information is such that Essity Aktiebolag (publ) is obligated to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 07:00 CET on May 7, 2026.

Karl Stoltz, Public relations Director, +46 (0) 709 426 338, karl.stoltz@essity.com

For further information, please contact:

Sandra Åberg, Vice President Investor Relations, +46 (0) 70 564 96 89, sandra.aberg@essity.com

Per Lorentz, Vice President Corporate Affairs +46 (0) 73 313 30 55, per.lorentz@essity.com